Takeda Pharmaceutical Co Ltd (TKPHF) FCF Margin (2018 - 2026)
Takeda Pharmaceutical (TKPHF) posted quarterly FCF Margin of 14.87% for Q2 2026, down 892.0% year-over-year from 1.88% in Q2 2025, and up 409.86% quarter-over-quarter from 4.8% in Q1 2026.
Takeda Pharmaceutical Co Ltd (TKPHF) FCF Margin (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's FCF Margin history runs 9 years deep, the most recent figure standing at 14.87% for Q2 2026.
- In Q2 2026, FCF Margin fell 892.0% year-over-year to 14.87%; the TTM figure through Jun 2026 stood at 13.55% (up 55.0% YoY), while the FY2026 annual figure was 23.04%, up 435.0% from the prior year.
- FCF Margin for Q2 2026 stood at 14.87%, up from 4.8% in the prior quarter.
- The five-year high for FCF Margin was 40.71% in Q4 2024, with the low at 10.81% in Q1 2025.
- The 5-year median for FCF Margin is 13.97% (2023), against an average of 15.29%.
- The sharpest annual moves came in 2023 and 2024: FCF Margin plunged 1913 bps in 2023, then soared 2229 bps in 2024.
- Takeda Pharmaceutical's FCF Margin stood at 37.54% in 2022, then sank by 51 bps to 18.42% in 2023, then jumped by 121 bps to 40.71% in 2024, then retreated by 7 bps to 37.91% in 2025, then plunged by 61 bps to 14.87% in 2026.
- Business Quant data shows TKPHF's FCF Margin at 14.87% in Q2 2026, 4.8% in Q1 2026, and 37.91% in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.87% |
| Mar 31, 2026 | -4.80% |
| Dec 31, 2025 | 37.91% |
| Sep 30, 2025 | 11.86% |
| Jun 30, 2025 | 23.80% |
| Mar 31, 2025 | -10.81% |
| Dec 31, 2024 | 40.71% |
| Sep 30, 2024 | 9.37% |
| Jun 30, 2024 | 18.85% |
| Mar 31, 2024 | -2.29% |
| Dec 31, 2023 | 18.42% |
| Sep 30, 2023 | 22.45% |
| Jun 30, 2023 | 13.07% |
| Mar 31, 2023 | -14.47% |
| Dec 31, 2022 | 37.54% |
| Sep 30, 2022 | 77.50% |
| Jun 30, 2022 | 12.99% |
| Mar 31, 2022 | 16.93% |
| Dec 31, 2021 | 41.56% |
| Sep 30, 2021 | 31.24% |